Welch Allyn Connex Cardio
CVE-2021-43935
CRITICAL
Severity by source
AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Lifecycle Timeline
1DescriptionNVD
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
AnalysisAI
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Technical ContextAI
This vulnerability is classified under CWE-288. The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges. Affected products include: Baxter Welch Allyn Connex Cardio, Baxter Welch Allyn Diagnostic Cardiology Suite, Baxter Welch Allyn Rscribe Resting Ecg System, Baxter Welch Allyn Vision Express Holter Analysis System, Baxter Welch Allyn Hscribe Holter Analysis System Firmware.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.
Same technique Authentication Bypass
View allShare
External POC / Exploit Code
Leaving vuln.today